![]()
Dosage ; see below
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ltd. | Ltd | 450mg/50mg | 30 | Tablet | per tablet | KES | |
| Ltd | (K) Ltd. | 450mg/50mg | 30 | Tablet | per tablet | KES |
| Prazosin More info | |
|---|---|
| Drug Indication | Hypertension; congestive heart failure; raynauds syndrome; benign prostatic hyperplasia. |
| Precautions | First dose may cause collapse due to hypotension (therefore should be taken on retiring to bed); elderly; cataract surgery (risk of intra-operative floppy iris syndrome); may affect performance of skilled tasks e.g. driving. |
| Contra-Indications | Congestive heart failure due to mechanical obstruction (e.g. aortic stenosis).hepatic impairment; renal impairment; pregnancy; breast-feeding. |
| Side Effects | Dyspnoea; nervousness; urinary frequency; less commonly insomnia, paraesthesia, sweating, arthralgia, eye disorders, tinnitus, and epistaxis; rarely pancreatitis, flushing, vasculitis, bradycardia, hallucinations, worsening of narcolepsy, gynaecomastia, urinary incontinence, and alopecia. |
| Dosage | Hypertension, 500mcg 2-3 times daily for 3-7 days, the initial dose on retiring to bed at night (to avoid collapse, see cautions); increased to 1mg 2-3 times daily for a further 3-7 days; further increased if necessary to max. 20mg daily in divided doses. Congestive heart failure 500mcg 2-4 times daily (initial dose at bedtime), increasing to 4mg daily in divided doses; maintenance 4-20mg daily in divided doses (but rarely used). Raynauds syndrome (but efficacy not established, initially 500mcg twice daily (initial dose at bedtime) increased, if necessary, after 3-7 days to usual maintenance 1-2mg twice daily. |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Alpha-adrenoceptor blocking agents |